Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout.

3,5-Di-tert-butylbenzaldehyde may be used in the synthesis of the following:5-p-pyridyl-15-(3,5-di-tert-butylphenyl)porphyrin via condensation reaction with 4-pyridinecarboxaldehyde and 2,2′-dipyrrylmethane.3,5-di-tert-butylphenyl-dipyrromethane via reaction with pyrrole in the presence of trifluoroacetic acid.3,5-di-tert-butyl-2-nitrobenzaldehyde via nitration reaction.

DCZ3301 is a novel aryl-guanidino inhibitor.